Flagship Ventures Fund Iv, L.p.

Affiliations

  • Large Shareholder at Rubius Therapeutics Inc. (RUBY), 2021-03-23
  • Large Shareholder at Kaleido Biosciences Inc. (KLDO), 2021-02-10
  • Large Shareholder at Evelo Biosciences Inc. (EVLO), 2021-02-04
  • Large Shareholder at Seres Therapeutics Inc. (MCRB), 2020-11-25
  • Large Shareholder at Moderna Inc. (MRNA), 2020-08-20
  • Large Shareholder at Axcella Health Inc. (AXLA), 2020-05-20
  • Large Shareholder at Transmedics Group Inc. (TMDX), 2019-10-31
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2017-08-21
  • Large Shareholder at Eleven Biotherapeutics Inc. (EBIO), 2016-09-26
  • Large Shareholder at Editas Medicine Inc. (EDIT), 2016-08-15
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2014-08-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SYRS $12.50 80,000 Large Shareholder 918,664 2016-07-06 Filing
SYRS $12.50 320,000 Large Shareholder 3,674,660 2016-07-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EBIO $3.10 10,293 Large Shareholder 106,787 2016-09-23 Filing
EBIO $3.10 41,178 Large Shareholder 426,885 2016-09-23 Filing
EBIO $3.16 3,118 Large Shareholder 117,080 2016-09-23 Filing
EBIO $3.16 12,482 Large Shareholder 468,063 2016-09-23 Filing
EBIO $3.17 47,090 Large Shareholder 120,198 2016-09-22 Filing